Research Unit of Philosophy of Science and Human Development, University Campus Bio-Medico of Rome, 00128 Rome, Italy.
Systems Biology Group Lab, Department of Experimental Medicine, Sapienza University, 00185 Rome, Italy.
Biomolecules. 2023 Apr 24;13(5):733. doi: 10.3390/biom13050733.
A growing number of studies shows that it is possible to induce a phenotypic transformation of cancer cells from malignant to benign. This process is currently known as "tumor reversion". However, the concept of reversibility hardly fits the current cancer models, according to which gene mutations are considered the primary cause of cancer. Indeed, if gene mutations are causative carcinogenic factors, and if gene mutations are irreversible, how long should cancer be considered as an irreversible process? In fact, there is some evidence that intrinsic plasticity of cancerous cells may be therapeutically exploited to promote a phenotypic reprogramming, both in vitro and in vivo. Not only are studies on tumor reversion highlighting a new, exciting research approach, but they are also pushing science to look for new epistemological tools capable of better modeling cancer.
越来越多的研究表明,有可能诱导癌细胞从恶性向良性的表型转化。这个过程目前被称为“肿瘤逆转”。然而,根据目前的癌症模型,这种可逆转性的概念很难被接受,因为这些模型认为基因突变是癌症的主要原因。事实上,如果基因突变是致癌的因素,而且如果基因突变是不可逆的,那么癌症应该被认为是一个不可逆的过程有多长时间?事实上,有一些证据表明,癌细胞的内在可塑性可能可以被治疗性地利用,以促进表型重编程,无论是在体外还是体内。肿瘤逆转的研究不仅突出了一种新的、令人兴奋的研究方法,而且还促使科学界寻找新的认识论工具,以更好地对癌症进行建模。